Target intelligence / Profile preview

Zinc finger protein 200 (ZNF200)

Target
ZNF200
Molecular classification
Transcription factor, C2H2-type zinc finger protein, KRAB domain-containing protein (Krüppel-associated box)
01

Overview

Zinc finger protein 200 (ZNF200) is a human protein encoded by the ZNF200 gene. It belongs to the C2H2-type zinc finger family and contains a Krüppel-associated box (KRAB) domain, a feature common to many transcription factors involved in gene regulation[4][6][10]. ZNF200 is predicted to bind nucleic acids and locate to the nucleus[1][2][7][12]. Functional studies show it interacts with key nuclear regulators: it binds directly to G9a (EHMT2), a histone H3 lysine 9 methyltransferase, and with PRMT3, a protein arginine methyltransferase; these interactions suggest it may modulate epigenetic regulation by affecting histone methylation[2][3][11]. The biological role of ZNF200 is incompletely characterized. It may participate in gene expression control, protein localization, and nuclear processes, and there is suggestive evidence for a role in spermatogenesis[1]. ZNF200 has been associated with rare genetic diseases, but it is not a validated or actionable therapeutic target at present[1][4][12]. Its role in human health and disease is primarily inferred from its molecular interactions and gene family, rather than direct evidence from pharmacological or clinical studies.

Other names
ZNF200Zinc finger protein 200ZNFMFZN200_HUMAN
02

Mechanism of action

Not applicable—no drugs directly target ZNF200.

03

Biological functions

Nucleic acid binding (DNA-binding transcription factor activity, predicted)Metal ion (zinc) bindingProtein localization to nucleusRegulation of gene expression and epigenetic mechanisms (interacts with histone methyltransferase G9a and arginine methyltransferase PRMT3, modulating histone modifications)Possible involvement in spermatogenesis (suggested, but not fully characterized)
04

Disease associations

Holoprosencephaly 12 (with or without pancreatic agenesis; associated via genetic studies)Osteogenesis imperfecta, Type VII (associated via genetic studies)No established direct role in major disease categories such as cancer, inflammation, neurodegenerative disease, or cardiovascular disease—the disease associations may reflect a genetic linkage or pleiotropic effects rather than a direct mechanistic role

Beyond the preview

Go deeper on Zinc finger protein 200 (ZNF200).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 200 (ZNF200).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call